Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Apply
XL092 & Nivolumab
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step